FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040708652> ?p ?o ?g. }

• W2040708652 endingPage "423" @default.
• W2040708652 startingPage "416" @default.
• W2040708652 abstract "Enzyme analysis for Pompe disease in leukocytes has been greatly improved by the introduction of acarbose, a powerful inhibitor of interfering alpha-glucosidases, which are present in granulocytes but not in lymphocytes. Here we show that the application of acarbose in the enzymatic assay employing the artificial substrate 4-methylumbelliferyl-alpha-D: -glucoside (MU-alphaGlc) is insufficient to clearly distinguish patients from healthy individuals in all cases. Also, the ratios of the activities without/with acarbose only marginally discriminated Pompe patients and healthy individuals. By contrast, when the natural substrate glycogen is used, the activity in leukocytes from patients (n = 82) with Pompe disease is at most 17% of the lowest control value. The use of artificial substrate in an assay with isolated lymphocytes instead of total leukocytes is a poor alternative as blood samples older than one day invariably yield lymphocyte preparations that are contaminated with granulocytes. To diagnose Pompe disease in leukocytes we recommend the use of glycogen as substrate in the presence of acarbose. This assay unequivocally excludes Pompe disease. To also exclude pseudo-deficiency of acid alpha-glucosidase caused by the sequence change c.271G>A (p.D91N or GAA2; homozygosity in approximately 1:1000 caucasians), a second assay employing MU-alphaGlc substrate plus acarbose or DNA analysis is required." @default.
• W2040708652 created "2016-06-24" @default.
• W2040708652 creator A5009631036 @default.
• W2040708652 creator A5011966740 @default.
• W2040708652 creator A5029347219 @default.
• W2040708652 creator A5030843902 @default.
• W2040708652 creator A5058241686 @default.
• W2040708652 creator A5058887960 @default.
• W2040708652 creator A5068738443 @default.
• W2040708652 creator A5083925269 @default.
• W2040708652 creator A5088193090 @default.
• W2040708652 creator A5089395276 @default.
• W2040708652 date "2009-04-19" @default.
• W2040708652 modified "2023-10-16" @default.
• W2040708652 title "Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates" @default.
• W2040708652 cites W1974391830 @default.
• W2040708652 cites W1998670393 @default.
• W2040708652 cites W2000753864 @default.
• W2040708652 cites W2005485363 @default.
• W2040708652 cites W2011982052 @default.
• W2040708652 cites W2025742657 @default.
• W2040708652 cites W2049457070 @default.
• W2040708652 cites W2056350789 @default.
• W2040708652 cites W2064921107 @default.
• W2040708652 cites W2072319599 @default.
• W2040708652 cites W2075594211 @default.
• W2040708652 cites W2081110699 @default.
• W2040708652 cites W2095643828 @default.
• W2040708652 cites W2100957628 @default.
• W2040708652 cites W2102833178 @default.
• W2040708652 cites W2159962592 @default.
• W2040708652 cites W2167531056 @default.
• W2040708652 doi "https://doi.org/10.1007/s10545-009-1082-3" @default.
• W2040708652 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19387865" @default.
• W2040708652 hasPublicationYear "2009" @default.
• W2040708652 type Work @default.
• W2040708652 sameAs 2040708652 @default.
• W2040708652 citedByCount "23" @default.
• W2040708652 countsByYear W20407086522012 @default.
• W2040708652 countsByYear W20407086522013 @default.
• W2040708652 countsByYear W20407086522016 @default.
• W2040708652 countsByYear W20407086522018 @default.
• W2040708652 countsByYear W20407086522019 @default.
• W2040708652 countsByYear W20407086522020 @default.
• W2040708652 countsByYear W20407086522021 @default.
• W2040708652 countsByYear W20407086522023 @default.
• W2040708652 crossrefType "journal-article" @default.
• W2040708652 hasAuthorship W2040708652A5009631036 @default.
• W2040708652 hasAuthorship W2040708652A5011966740 @default.
• W2040708652 hasAuthorship W2040708652A5029347219 @default.
• W2040708652 hasAuthorship W2040708652A5030843902 @default.
• W2040708652 hasAuthorship W2040708652A5058241686 @default.
• W2040708652 hasAuthorship W2040708652A5058887960 @default.
• W2040708652 hasAuthorship W2040708652A5068738443 @default.
• W2040708652 hasAuthorship W2040708652A5083925269 @default.
• W2040708652 hasAuthorship W2040708652A5088193090 @default.
• W2040708652 hasAuthorship W2040708652A5089395276 @default.
• W2040708652 hasConcept C126322002 @default.
• W2040708652 hasConcept C181199279 @default.
• W2040708652 hasConcept C18903297 @default.
• W2040708652 hasConcept C203014093 @default.
• W2040708652 hasConcept C2776617576 @default.
• W2040708652 hasConcept C2776735236 @default.
• W2040708652 hasConcept C2777289219 @default.
• W2040708652 hasConcept C2777499176 @default.
• W2040708652 hasConcept C2777761686 @default.
• W2040708652 hasConcept C2779134260 @default.
• W2040708652 hasConcept C2779468605 @default.
• W2040708652 hasConcept C2779969927 @default.
• W2040708652 hasConcept C55493867 @default.
• W2040708652 hasConcept C71924100 @default.
• W2040708652 hasConcept C86803240 @default.
• W2040708652 hasConceptScore W2040708652C126322002 @default.
• W2040708652 hasConceptScore W2040708652C181199279 @default.
• W2040708652 hasConceptScore W2040708652C18903297 @default.
• W2040708652 hasConceptScore W2040708652C203014093 @default.
• W2040708652 hasConceptScore W2040708652C2776617576 @default.
• W2040708652 hasConceptScore W2040708652C2776735236 @default.
• W2040708652 hasConceptScore W2040708652C2777289219 @default.
• W2040708652 hasConceptScore W2040708652C2777499176 @default.
• W2040708652 hasConceptScore W2040708652C2777761686 @default.
• W2040708652 hasConceptScore W2040708652C2779134260 @default.
• W2040708652 hasConceptScore W2040708652C2779468605 @default.
• W2040708652 hasConceptScore W2040708652C2779969927 @default.
• W2040708652 hasConceptScore W2040708652C55493867 @default.
• W2040708652 hasConceptScore W2040708652C71924100 @default.
• W2040708652 hasConceptScore W2040708652C86803240 @default.
• W2040708652 hasIssue "3" @default.
• W2040708652 hasLocation W20407086521 @default.
• W2040708652 hasLocation W20407086522 @default.
• W2040708652 hasOpenAccess W2040708652 @default.
• W2040708652 hasPrimaryLocation W20407086521 @default.
• W2040708652 hasRelatedWork W1988310651 @default.
• W2040708652 hasRelatedWork W1997053742 @default.
• W2040708652 hasRelatedWork W2009928958 @default.
• W2040708652 hasRelatedWork W2022807266 @default.
• W2040708652 hasRelatedWork W202703229 @default.
• W2040708652 hasRelatedWork W2078718267 @default.

• next